Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Common Equity (2016 - 2025)

Historic Common Equity for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $238.9 million.

  • Mimedx's Common Equity rose 3200.85% to $238.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.9 million, marking a year-over-year increase of 3200.85%. This contributed to the annual value of $193.1 million for FY2024, which is 3530.76% up from last year.
  • Latest data reveals that Mimedx reported Common Equity of $238.9 million as of Q3 2025, which was up 3200.85% from $216.6 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx's Common Equity peaked at $238.9 million during Q3 2025, and registered a low of -$19.5 million during Q3 2022.
  • In the last 5 years, Mimedx's Common Equity had a median value of $82000.0 in 2021 and averaged $73.2 million.
  • Per our database at Business Quant, Mimedx's Common Equity crashed by 2203658.54% in 2022 and then soared by 1350962.41% in 2024.
  • Mimedx's Common Equity (Quarter) stood at $82000.0 in 2021, then crashed by 22036.59% to -$18.0 million in 2022, then surged by 893.4% to $142.7 million in 2023, then skyrocketed by 35.31% to $193.1 million in 2024, then increased by 23.74% to $238.9 million in 2025.
  • Its last three reported values are $238.9 million in Q3 2025, $216.6 million for Q2 2025, and $202.8 million during Q1 2025.